Cardiovascular disease (CVD) is a global epidemic, compounded by diabetes and other chronic illnesses.
We Can Help

SphygomorCor® offers a better way to detect CVD earlier and target treatment for each individual patient.

Central blood pressure is the best predictor of cardiovascular risk.

SphygomorCor® is the industry standard for noninvasive central blood pressure (NcBP) and arterial stiffness - vital data that deliver deep, individual clinical insights.
Learn More
SphygomorCor® XCEL integrates seamlessly into standard clinical workflows. Noninvasive central blood pressure (NcBP) and other unique data can help physicians personalize medications and get patients to goal faster.
Learn More
SphygomorCor® by the numbers
Homepage Latest

All “Top 20 Hospitals” use SphygmoCor technology to measure central blood pressure (cBP)

Homepage Latest

1,400+ studies using the SphygmoCor technology have been published in peer-reviewed clinical publications.

Homepage Latest

8 out of Top 10 Pharma companies have used SphygmoCor technology in their clinical trials

Homepage Latest

Over 11,000 patients have been tested with SphygmoCor technology in pharmaceutical trials